Utah Medical Products (UTMD) Competitors $56.31 +0.61 (+1.10%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$56.22 -0.09 (-0.17%) As of 08/8/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAYShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Its Competitors Cerus OraSure Technologies Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk. Which has more volatility & risk, UTMD or CERS? Utah Medical Products has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Do analysts recommend UTMD or CERS? Cerus has a consensus target price of $3.50, indicating a potential upside of 189.26%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, UTMD or CERS? Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUtah Medical Products$40.90M4.47$13.87M$3.7415.06Cerus$180.27M1.29-$20.92M-$0.10-12.10 Does the media refer more to UTMD or CERS? In the previous week, Cerus had 5 more articles in the media than Utah Medical Products. MarketBeat recorded 7 mentions for Cerus and 2 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.61 beat Cerus' score of -0.39 indicating that Utah Medical Products is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Utah Medical Products 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Cerus 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Is UTMD or CERS more profitable? Utah Medical Products has a net margin of 32.34% compared to Cerus' net margin of -9.81%. Utah Medical Products' return on equity of 10.50% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Utah Medical Products32.34% 10.50% 10.05% Cerus -9.81%-33.77%-9.32% Do insiders and institutionals believe in UTMD or CERS? 69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 7.4% of Utah Medical Products shares are owned by company insiders. Comparatively, 5.6% of Cerus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryUtah Medical Products beats Cerus on 9 of the 16 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$182.91M$10.65B$5.51B$9.72BDividend Yield2.17%2.00%4.60%4.12%P/E Ratio15.0620.2530.0324.76Price / Sales4.4721.90452.4198.43Price / Cash11.4223.1136.7758.47Price / Book1.632.858.185.59Net Income$13.87M$211.77M$3.26B$265.99M7 Day Performance2.47%3.02%6.13%5.07%1 Month Performance-1.57%0.35%0.07%0.61%1 Year Performance-15.50%-9.81%36.31%22.83% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products3.3487 of 5 stars$56.31+1.1%N/A-15.5%$182.91M$40.90M15.06180Positive NewsCERSCerus2.8483 of 5 stars$1.30+2.4%$3.50+169.2%-43.5%$242.77M$185.14M-13.00290Earnings ReportAnalyst RevisionOSUROraSure Technologies1.8928 of 5 stars$3.12+3.7%$3.00-3.8%-34.1%$225.15M$185.83M-7.43840ANIKAnika Therapeutics4.529 of 5 stars$8.77+1.5%$18.00+105.2%-68.4%$123.91M$114.55M-2.11300WSTWest Pharmaceutical Services4.6095 of 5 stars$238.34-0.4%$320.71+34.6%-16.2%$17.20B$2.89B35.6810,600Positive NewsCOOCooper Companies3.5164 of 5 stars$71.45+0.8%$96.73+35.4%-24.5%$14.17B$3.90B34.6816,000ALGNAlign Technology4.9583 of 5 stars$137.77+0.9%$215.00+56.1%-34.9%$9.90B$4.00B23.2320,945Buyback AnnouncementMMSIMerit Medical Systems4.5083 of 5 stars$85.38+0.7%$107.00+25.3%-5.4%$5.02B$1.36B43.347,400HAEHaemonetics4.9314 of 5 stars$76.26+2.0%$97.30+27.6%-30.1%$3.59B$1.36B23.043,023Trending NewsEarnings ReportAnalyst ForecastICUIICU Medical4.5908 of 5 stars$130.06+2.1%$192.67+48.1%-26.1%$3.14B$2.38B-33.9615,000News CoverageEarnings ReportAnalyst ForecastGap DownXRAYDENTSPLY SIRONA4.9255 of 5 stars$14.31+0.1%$19.60+37.0%-46.3%$2.85B$3.72B-3.1514,000Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
